Aquestive Therapeutics Inc (AQST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.71% 10.00	8.72	11.87	13.54	20.10
Cost Of Revenue	24.89% 4.561	3.652	4.52	4.437	4.526
Gross Profit	7.38% 5.442	5.068	7.347	9.105	15.57
Operating Expenses	31.20% 16.81	24.43	20.93	17.39	15.52
Benefits Costs and Expenses	25.59% 23.55	31.65	28.94	25.05	22.84
Costs And Expenses	23.91% 21.37	28.09	25.45	21.83	20.04
Depreciation and Amortization	0.72% 0.14	0.139	0.147	0.159	0.205
Operating Income/Loss	41.30% -11.37	-19.36	-13.58	-8.29	0.055
Income/Loss From Continuing Operations Before Tax	40.92% -13.55	-22.93	-17.07	-11.51	-2.745
Income Tax Expense/Benefit	-	-	-0.014	-	-
Income/Loss From Continuing Operations After Tax	40.92% -13.55	-22.93	-17.05	-11.51	-2.745
Net Income/Loss	40.92% -13.55	-22.93	-17.05	-11.51	-2.745
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4.01% 99.33	95.50	1.5019	91.08	90.91
Diluted Average Shares	4.01% 99.33	95.50	1.5019	91.08	90.91
Basic Earnings Per Share	41.67% -0.14	-0.24	-0.19	-0.13	-0.03
Diluted Earnings Per Share	41.67% -0.14	-0.24	-0.19	-0.13	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$28.92

3.60%

ELAN

$17.47

0.69%

RDY

$14.15

0.28%

VTRS

$10.33

2.09%

NBIX

$140.40

3.15%

UTHR

$380.47

2.80%